Autor: Ian M. Hann

Professor Robert Arceci is a world leader in the care of children with leukaemia and especially acute myeloid leukaemia. He edits the main Paediatric Haematology and Oncology journal, ‘Pediatric Blood & Cancer’ and his research is mainly into new agents for leukaemia therapy and the scientific basis for their actions. Professor Ian Hann is chair of the national NRCN task force on ALL. He is associate medical director of Great Ormond Street Hospital (GOS) and Professor and academic lead in Paediatric Haematology and Oncology at GOS and the Institute of Child Health. He coordinates the current national trial in ALL (ALL trial 2003) and is national coordinator of the international trial in infant leukaemia – Interfant. He is also Editor of the British Journal of Haematology. Professor Owen Smith is academic lead for Paediatric Haematology and Oncology at the National Children’s Hospital and Trinity College, Dublin. He is a world expert on Shwachmann”s syndrome and has carried out world-ranking research on protein C. He is national coordinator for UK and Ireland of the International relapsed AML trial.